IIB 
115TH CONGRESS 
2D SESSION 
H. R. 4284 
IN THE SENATE OF THE UNITED STATES 
JUNE 13, 2018 
Received; read twice and referred to the Committee on Health, Education, 
Labor, and Pensions 
AN ACT 
To establish a substance use disorder information dashboard 
within the Department of Health and Human Services, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Indexing Narcotics, 
Fentanyl, and Opioids Act of 2018’’ or the ‘‘INFO Act’’. 
SEC. 2. ESTABLISHMENT OF SUBSTANCE USE DISORDER IN-
FORMATION DASHBOARD. 
Title XVII of the Public Health Service Act (42 
U.S.C. 300u et seq.) is amended by adding at the end 
the following new section: 
‘‘SEC. 1711. ESTABLISHMENT OF SUBSTANCE USE DIS-
ORDER INFORMATION DASHBOARD. 
‘‘(a) IN GENERAL.—Not later than 6 months after 
the date of the enactment of this section, the Secretary 
of Health and Human Services shall, in consultation with 
the Director of National Drug Control Policy, establish 
and periodically update a public information dashboard 
that— 
‘‘(1) coordinates information on programs with-
in the Department of Health and Human Services 
related to the reduction of opioid abuse and other 
substance use disorders; 
‘‘(2) provides access to publicly available data 
from other Federal agencies; State, local, and Tribal 
governments; nonprofit organizations; law enforce-
ment; medical experts; public health educators; and 
research institutions regarding prevention, treat-
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
ment, recovery, and other services for opioid use dis-
order and other substance use disorders; 
‘‘(3) provides comparable data on substance use 
disorder prevention and treatment strategies in dif-
ferent regions and population of the United States; 
‘‘(4) provides recommendations for health care 
providers on alternatives to controlled substances for 
pain management, including approaches studied by 
the National Institutes of Health Pain Consortium 
and the National Center for Complimentary and In-
tegrative Health; and 
‘‘(5) provides guidelines and best practices for 
health care providers regarding treatment of sub-
stance use disorders. 
‘‘(b) CONTROLLED SUBSTANCE DEFINED.—In this 
section, the term ‘controlled substance’ has the meaning 
given that term in section 102 of the Controlled Sub-
stances Act (21 U.S.C. 802).’’. 
SEC. 3. INTERAGENCY SUBSTANCE USE DISORDER COORDI-
NATING COMMITTEE. 
(a) ESTABLISHMENT.—Not later than 3 months after 
the date of the enactment of this Act, the Secretary of 
Health and Human Services (in this section referred to 
as the ‘‘Secretary’’) shall, in consultation with the Direc-
tor of National Drug Control Policy, establish a com-
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
mittee, to be known as the Interagency Substance Use 
Disorder Coordinating Committee (in this section referred 
to as the ‘‘Committee’’), to coordinate all efforts within 
the Department of Health and Human Services con-
cerning substance use disorder. 
(b) MEMBERSHIP.— 
(1) FEDERAL MEMBERS.—The following indi-
viduals shall be the Federal members of the Com-
mittee: 
(A) The Secretary, who shall service as the 
Chair of the Committee. 
(B) The Attorney General of the United 
States. 
(C) The Secretary of Labor. 
(D) The Secretary of Housing and Urban 
Development. 
(E) The Secretary of Education. 
(F) The Secretary of Veterans Affairs. 
(G) The Commissioner of Social Security. 
(H) The Assistant Secretary for Mental 
Health and Substance Use. 
(I) The Director of the Centers for Disease 
Control and Prevention. 
(J) The Director of the National Institutes 
of Health and the Directors of such national re-
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
search institutes of the National Institutes of 
Health as the Secretary determines appropriate. 
(K) The Administrator of the Centers for 
Medicare & Medicaid Services. 
(L) The Director of National Drug Control 
Policy. 
(M) Representatives of other Federal agen-
cies that serve individuals with substance use 
disorder. 
(2) NON-FEDERAL MEMBERS.—The Committee 
shall include a minimum of 17 non-Federal members 
appointed by the Secretary, of which— 
(A) at least two such members shall be an 
individual who has received treatment for a di-
agnosis of an opioid use disorder; 
(B) at least two such members shall be an 
individual who has received treatment for a di-
agnosis of a substance use disorder other than 
an opioid use disorder; 
(C) at least two such members shall be a 
State Alcohol and Substance Abuse Director; 
(D) at least two such members shall be a 
representative of a leading research, advocacy, 
or service organization for adults with sub-
stance use disorder; 
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
(E) at least two such members shall— 
(i) be a physician, licensed mental 
health professional, advance practice reg-
istered nurse, or physician assistant; and 
(ii) have experience in treating indi-
viduals with opioid use disorder or other 
substance use disorders; 
(F) at least one such member shall be a 
substance use disorder treatment professional 
who is employed with an opioid treatment pro-
gram; 
(G) at least one such member shall be a 
substance use disorder treatment professional 
who has research or clinical experience in work-
ing with racial and ethnic minority populations; 
(H) at least one such member shall be a 
substance use disorder treatment professional 
who has research or clinical mental health expe-
rience in working with medically underserved 
populations; 
(I) at least one such member shall be a 
State-certified substance use disorder peer sup-
port specialist; 
(J) at least one such member shall be a 
drug court judge or a judge with experience in 
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
adjudicating cases related to substance use dis-
order; 
(K) at least one such member shall be a 
law enforcement officer or correctional officer 
with extensive experience in interacting with 
adults with a substance use disorder; and 
(L) at least one such member shall be an 
individual with experience providing services for 
homeless individuals and working with adults 
with a substance use disorder. 
(c) TERMS.— 
(1) IN GENERAL.—A member of the Committee 
appointed under subsection (b)(2) shall be appointed 
for a term of 3 years and may be reappointed for 
one or more 3-year terms. 
(2) VACANCIES.—A vacancy on the Committee 
shall be filled in the same manner in which the origi-
nal appointment was made. Any individual appointed 
to fill a vacancy for an unexpired term shall be ap-
pointed for the remainder of such term and may 
serve after the expiration of such term until a suc-
cessor has been appointed. 
(d) MEETINGS.—The Committee shall meet not fewer 
than two times each year. 
(e) DUTIES.—The Committee shall— 
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
(1) monitor opioid use disorder and other sub-
stance use disorder research, services, and support 
and prevention activities across all relevant Federal 
agencies, including coordination of Federal activities 
with respect to opioid use disorder and other sub-
stance use disorders; 
(2) identify and provide to the Secretary rec-
ommendations for improving Federal grants and 
programs for the prevention and treatment of, and 
recovery from, opioid use disorder and other sub-
stance use disorders; 
(3) review substance use disorder prevention 
and treatment strategies in different regions and 
populations in the United States and evaluate the 
extent to which Federal substance use disorder pre-
vention and treatment strategies are aligned with 
State and local substance use disorder prevention 
and treatment strategies; 
(4) make recommendations to the Secretary re-
garding any appropriate changes with respect to the 
activities and strategies described in paragraphs (1) 
through (3); 
(5) make recommendations to the Secretary re-
garding public participation in decisions relating to 
opioid use disorder and other substance use dis-
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS
HR 4284 RFS
orders and the process by which public feedback can 
be better integrated into such decisions; and 
(6) make recommendations to ensure that 
opioid use disorder and other substance use disorder 
research, services, and support and prevention activi-
ties of the Department of Health and Human Serv-
ices and other Federal agencies are not unneces-
sarily duplicative. 
(f) ANNUAL REPORT.— 
(1) IN GENERAL.—Not later than 1 year after 
the date of the enactment of this Act, and annually 
thereafter for the life of the Committee, the Com-
mittee shall publish on the public information dash-
board established under section 2(a) a report sum-
marizing the activities carried out by the Committee 
pursuant to subsection (e), including any findings 
resulting from such activities. 
(2) RECOMMENDATION
FOR
COMMITTEE
EX-
TENSION.—After the publication of the second re-
port of the Committee under paragraph (1), the Sec-
retary shall submit to Congress a recommendation 
on whether or not the operations of the Committee 
should continue after the termination date described 
in subsection (i). 
VerDate Sep 11 2014 
00:06 Jun 14, 2018
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H4284.RFS
H4284
lotter on DSKBCFDHB2PROD with BILLS